Stereoselective inhibition of human CYP2C19 activity by lansoprazole and omeprazole

  • Kim Min-Jung (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital) ;
  • Kim Kyung-Ah (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital) ;
  • Shon Ji-Hong (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital) ;
  • Lee Sang-Seop (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital) ;
  • Cha In-June (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital) ;
  • Shin Jae-Gook (Department of Pharmacology, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital)
  • Published : 2002.12.01